Landogrozumab Explained

Landogrozumab (INN; development code LY2495655) is a humanized monoclonal antibody and experimental pharmaceutical drug designed for the treatment of muscle wasting disorders.[1] [2]

The drug was developed by Eli Lilly and Company.

References

  1. http://www.ama-assn.org/resources/doc/usan/x-pub/landogrozumab.pdf Statement On A Nonproprietary Name Adopted By The USAN Council - Landogrozumab
  2. . International Nonproprietary Names for Pharmaceutical Substances (INN). Proposed INN: List 113 . WHO Drug Information . 29 . 2 . 2015 .

This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Landogrozumab".

Except where otherwise indicated, Everything.Explained.Today is © Copyright 2009-2025, A B Cryer, All Rights Reserved. Cookie policy.